Surgery News and Research

RSS

VBL team receives $100,000 award to track abdominal aortic aneurysms

The Vascular Bioengineering Lab at the University of Pittsburgh's Swanson School of Engineering seeks to understand and develop solutions to the causes and effects of disease in tubular tissue and organs.

19 Jul 2021

Researchers find a potentially game-changing blood clot treatment

A potentially game-changing treatment for people with, or at risk of, blood clots has been found effective by an international team of researchers led by McMaster University's Jeffrey Weitz.

19 Jul 2021

Chemical modification in RNA molecules may offer protection against liver disease

A chemical modification that occurs in some RNA molecules as they carry genetic instructions from DNA to cells' protein-making machinery may offer protection against non-alcoholic fatty liver, a condition that results from a build-up of fat in the liver and can lead to advanced liver disease, according to a new study by UCLA researchers.

19 Jul 2021

Novel robotic neck brace may help doctors to analyze neck mobility in cancer patients

A new robotic neck brace from researchers at Columbia Engineering and their colleagues at Columbia's Department of Otolaryngology may help doctors analyze the impact of cancer treatments on the neck mobility of patients and guide their recovery.

19 Jul 2021

Researchers use appendiceal cancer organoids to study personalized immunotherapy response

Wake Forest researchers and clinicians are using patient-specific tumor 'organoid' models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer, one of the rarest cancers affecting only 1 in 100,000 people.

19 Jul 2021

Survival for babies born with congenital anomalies depends on place of birth

Survival for a baby born with a birth defect – otherwise known as a congenital anomaly – is dependent on where you are born, a new study reveals.

19 Jul 2021

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

19 Jul 2021

UCSF researchers discover how the immune system may play a role in miscarriage

Researchers at UC San Francisco are zeroing in on how the immune system may play a role in miscarriage, which affects about a quarter of pregnancies.

16 Jul 2021

Gene therapy delivered into the brain may be safe, effective in treating rare neurological disorder

A new study published in Nature Communications suggests that gene therapy delivered into the brain may be safe and effective in treating aromatic L-amino acid decarboxylase (AADC) deficiency.

16 Jul 2021

Brain signals translated into speech give paralyzed man back his words

Scientists at UC San Francisco have successfully developed a "speech neuroprosthesis" device that has enabled a man with severe paralysis to communicate in sentences, translating signals from his brain to text on a screen.

15 Jul 2021

Researchers identify a new, promising biomarker for bacterial soft tissue infections

Rapid diagnosis is crucial in bacterial soft tissue infections to reduce the risk of severe injury or amputation.

15 Jul 2021

Antihypertension drug may benefit patients with neurofibromatosis type 2

New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.

15 Jul 2021

Short chain fatty acids have potential therapeutic applications against COVID-19, study suggests

SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is highly transmissible, with nasal passages being the target of original infection.

15 Jul 2021

Drug combination found to be safe and effective in malignant peritoneal mesothelioma patients

A phase II study led by researchers from The University of Texas MD Anderson Cancer Center found that treatment with atezolizumab and bevacizumab was well-tolerated and resulted in a 40% objective response rate in patients with advanced malignant peritoneal mesothelioma, a rare cancer in the lining of the abdomen.

14 Jul 2021

Minimally invasive exosome spray may help repair the heart after myocardial infarction

Heart attack, or myocardial infarction, is one of the leading causes of death worldwide. Although modern surgical techniques, diagnostics and medications have greatly improved early survival from these events, many patients struggle with the long-term effects of permanently damaged tissue, and the 5-year mortality rate remains high.

14 Jul 2021

New treatment that uses 3D printed implants could bring relief to knee osteoarthritis sufferers

Pioneering 'printed metal' procedure to create bespoke treatment for early knee osteoarthritis set to be trialled in the UK following MHRA approval.

14 Jul 2021

Latest ATS/CSL Behring research grant recipient focuses on COVID-19 ARDS study

The ATS Research Program is pleased to announce that William Zhang, MD, of Weill Cornell Medical Center is the recipient of the 2020-2021 ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome.

13 Jul 2021

New study focuses on personalized therapies for people with severe asthma

A new phase 2 clinical trial of multiple therapies for severe asthma is underway in Northeast Ohio, with a focus on personalized therapies based on genetics, family history, lifestyle and environmental factors.

13 Jul 2021

Selective immunotoxins may help treat liver fibrosis

Chronic alcohol abuse and hepatitis can injure the liver and lead to fibrosis, the buildup of collagen and scar tissue. As a potential approach to treating liver fibrosis, University of California San Diego School of Medicine researchers and their collaborators are looking for ways to stop liver cells from producing collagen.

12 Jul 2021

Gene therapy shows promise in children with devastating genetic disorder

Children with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children's Hospitals.

12 Jul 2021

Surgery News and Research

VBL team receives $100,000 award to track abdominal aortic aneurysms

Researchers find a potentially game-changing blood clot treatment

Chemical modification in RNA molecules may offer protection against liver disease

Novel robotic neck brace may help doctors to analyze neck mobility in cancer patients

Researchers use appendiceal cancer organoids to study personalized immunotherapy response

Survival for babies born with congenital anomalies depends on place of birth

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

UCSF researchers discover how the immune system may play a role in miscarriage

Gene therapy delivered into the brain may be safe, effective in treating rare neurological disorder

Brain signals translated into speech give paralyzed man back his words

Researchers identify a new, promising biomarker for bacterial soft tissue infections

Antihypertension drug may benefit patients with neurofibromatosis type 2

Short chain fatty acids have potential therapeutic applications against COVID-19, study suggests

Drug combination found to be safe and effective in malignant peritoneal mesothelioma patients

Minimally invasive exosome spray may help repair the heart after myocardial infarction

New treatment that uses 3D printed implants could bring relief to knee osteoarthritis sufferers

Latest ATS/CSL Behring research grant recipient focuses on COVID-19 ARDS study

New study focuses on personalized therapies for people with severe asthma

Selective immunotoxins may help treat liver fibrosis

Gene therapy shows promise in children with devastating genetic disorder

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News